Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jul 17, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Peripheral neuroblastic tumours in eastern Denmark 1972-2002.

Zarah Glad Zimling¹, Catherine Rechnitzer, Marianne Rasmussen

¹Department of Pathology, University of Copenhagen, Denmark.

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica

|January 17, 2007

Summary

This study on childhood neuroblastoma found MYCN gene amplification is a stronger predictor of survival than histological classification. MYCN amplification significantly impacts prognosis in peripheral neuroblastic tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Moderate levels of high-frequency noise mask harbor porpoise hearing, but do not cause temporary threshold shift.

The Journal of the Acoustical Society of America·2025

Same author

Diabetes Mellitus and Metabolic Profile in Long-Term Survivors of Wilms Tumor: A Nationwide Cohort Study With Sibling Controls.

Pediatric blood & cancer·2025

Same author

Treatment-Related Risk Factors for Diabetes Mellitus in Childhood Cancer Survivors-A Case-Cohort Study Within Adult Life After Childhood Cancer in Scandinavia (ALiCCS).

Pediatric blood & cancer·2025

Same author

Late-onset epilepsy in survivors of childhood cancer outside the central nervous system: a study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study.

Journal of cancer survivorship : research and practice·2025

Same author

Induction Therapies Determine the Distribution of Perforin and Granzyme B Transcripts in Kidney Transplant Recipients.

Biomedicines·2024

Same author

Long non-coding RNA MGAT3 in kidney transplant recipients with immunoglobulin A nephropathy.

Journal of nephrology·2024

Area of Science:

Pediatric Oncology
Cancer Genetics
Tumor Biology

Background:

Peripheral neuroblastic tumors, including neuroblastoma, are common extracranial solid tumors in children.
Accurate prognostic markers are crucial for guiding treatment and improving outcomes.

Purpose of the Study:

To evaluate the prognostic significance of histological presentation and MYCN gene status in peripheral neuroblastic tumors.
To compare the predictive power of MYCN amplification versus histological classification for 5-year survival.

Main Methods:

Retrospective analysis of 125 patients diagnosed between 1972-2002 in eastern Denmark.
Histological review using the Shimada classification system and MYCN status determination via FISH analysis.
Calculation of diagnostic likelihood ratios to compare prognostic markers.

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Experiment Videos

Last Updated: Jul 17, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Main Results:

Unfavourable histology was associated with widespread disease (p<0.001).
5-year survival rates were 30% for unfavourable histology, 100% for favourable histology, and 13% for unclassifiable tumors.
MYCN amplification (26% of cases) was linked to undifferentiated histology and showed a higher positive diagnostic likelihood ratio (4.7) than unfavourable histology (2.9).

Conclusions:

The Shimada histological classification retains prognostic significance for peripheral neuroblastic tumors.
MYCN gene amplification is a superior prognostic marker compared to histological classification, potentially reducing the required tumor tissue for diagnosis.